Show simple item record

dc.contributor.authorWakasiaka, Sabina
dc.contributor.authorBwayo, JJ
dc.contributor.authorNdinya-Achola, JO
dc.contributor.authorOmosa, Gloria
dc.contributor.authorJaoko, Walter
dc.contributor.authorWaruingi, Wambui
dc.contributor.authorOgutu, Hilda
dc.date.accessioned2013-04-04T06:25:31Z
dc.date.available2013-04-04T06:25:31Z
dc.date.issued2004
dc.identifier.citationKenya AIDS Vaccine Initiative HIV Vaccine Peer Leaders Training Manualen
dc.identifier.urihttp://hdl.handle.net/11295/15247
dc.description.abstractMRC Human Immunology Unit, University of Oxford, Oxford, UK. The IFN-y enzyme-linked immunospot (ELI-Spot) assay is often used to map HIV-specific CD8 T-cell responses. We compared overlapping 15-mer pools with optimized CD8 epitopes to screen ELISpot responses in HIV-infected individuals. The 15-mer pools detected responses to previously undefined epitopes, but often missed low-level responses to predefined epitopes, particularly when the epitope was central in the 15-mer, rather than at the N-terminus or C-terminus. These factors should be considered in the monitoring of HIV vaccine trials.en
dc.language.isoenen
dc.titleKenya AIDS Vaccine Initiative HIV Vaccine Peer Leaders Training Manualen
dc.typeOtheren
local.publisherKAVI Dept. of Medical Microbiologyen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record